Tala de los Santos - Concepedia

Author

Tala de los Santos

Program for Appropriate Technology in Health ORCID

Also Known As

T De Los Santos, T de los Santos, T. De Los Santos, Tala de los Santos, Tala de los Santos

Publications

736

Citations

H-Index

Concepts

All Affiliations

Program for Appropriate Technology in Health National Institute of Allergy and Infectious Diseases National Institutes of Health Erasmus MC University of South Florida

About

Tala de los Santos is an author at Program for Appropriate Technology in Health specializing in medicine, public health, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	310
2	Engineering	1	1	42
3	Health Sciences	1	1	65
4	Natural Sciences	1	1	129
5	Nursing	1	1	42

Tala de los Santos

Publications

609

Citations

H-Index

Page 1

	Year	Citations
Small Evolutionarily Conserved RNA, Resembling C/D Box Small Nucleolar RNA, Is Transcribed from PWCR1, a Novel Imprinted Gene in the Prader-Willi Deletion Region, Which Is Highly Expressed in Brain Tala de los Santos, Johannes Schweizer, Christian A. Rees, The American Journal of Human Genetics Novel Imprinted GeneNatural SciencesGeneticsRna BiologyMolecular Biology	2000	129
Extended Result Reading Window in Lateral Flow Tests Detecting Exposure to Onchocerca volvulus: A New Technology to Improve Epidemiological Surveillance Tools Allison Golden, Cathy Steel, Lindsay Yokobe, PLoS ONE	2013	79
Rapid Point-of-Contact Tool for Mapping and Integrated Surveillance of Wuchereria bancrofti and Onchocerca volvulus Infection Cathy Steel, Allison Golden, Eric Stevens, Clinical and Vaccine Immunology Pathogen DetectionImmunologyRapid Point-of-contact ToolIntegrated SurveillancePathogen Transmission	2015	65
Rapid Wuchereria bancrofti-Specific Antigen Wb123-Based IgG4 Immunoassays as Tools for Surveillance following Mass Drug Administration Programs on Lymphatic Filariasis Cathy Steel, Allison Golden, Joseph Kubofcik, Clinical and Vaccine Immunology	2013	62
Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis Allison Golden, Dunia Faulx, Michael Kalnoky, Parasites & Vectors	2016	53
Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes Yvonne L. Lont, Luc E. Coffeng, Sake J. de Vlas, PLoS neglected tropical diseases	2017	46
Feasibility of utilizing the SD BIOLINE Onchocerciasis IgG4 rapid test in onchocerciasis surveillance in Senegal Yakou Dieye, Helen L. Storey, Kelsey L. Barrett, PLoS neglected tropical diseases Total CostEvidence-based MedicineDiagnosisPathologyDermatology	2017	45
The Value of Clinical Needs Assessments for Point-of-Care Diagnostics Bernhard H. Weigl, Charlotte A. Gaydos, Gerald J. Kost, Point of Care The Journal of Near-Patient Testing & Technology Health AssessmentNew TechnologiesEngineeringPoint-of-care TestingMedical Technology	2012	42
A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus Allison Golden, Eric Stevens, Lindsay Yokobe, PLoS neglected tropical diseases	2016	33
Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis Luc E. Coffeng, Wilma A. Stolk, Allison Golden, American Journal of Epidemiology World Health OrganizationEpidemiologic ResearchPathologyPredictive ValueDifferent Subpopulations	2019	29

Page 1